(TOP (S (NP (NP (DT A) (JJ new) (NN drug)) (SBAR (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN rejection)) (PP (IN of) (NP (JJ transplanted) (NNS organs))))))))) (VP (AUX has) (VP (AUX been) (VP (ADVP (RB successfully)) (VBN used) (PP (IN on) (NP (QP (JJR more) (IN than) (CD 100)) (NNS patients))) (PP (IN at) (NP (organization (NP (DT the) (NNP University)) (PP (IN of) (NP (location (NNP Pittsburgh))))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NNS researchers))))))) (. .)) )
(TOP (S (S (NP (NP (DT The) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (AUX is) (ADVP (RB still)) (PP (IN in) (NP (DT the) (JJ experimental) (NN phase)))))) (, ,)) (VP (AUX has) (RB n't) (VP (AUX been) (VP (VBN approved) (ADVP (RB yet)) (PP (IN by) (NP (DT the) (organization (NNP Food) (CC and) (NNP Drug) (NNP Admistration)))))))) (, ,) (CC and) (S (NP (PRP$ its) (JJ long-term) (NNS effects)) (VP (AUX are) (ADJP (JJ unknown)))) (. .)) )
(TOP (S (CC But) (NP (NNS researchers)) (VP (VBP say) (SBAR (S (NP (NP (DT the) (NN drug)) (, ,) (VP (VBN called) (S (NP (NNP FK-506)))) (, ,)) (VP (MD could) (VP (VB revolutionize) (NP (DT the) (NN transplantation) (NN field)) (PP (PP (IN by) (S (VP (VBG reducing) (NP (JJ harmful) (NN side) (NNS effects))))) (CC and) (PP (IN by) (S (VP (VBG lowering) (NP (NN rejection) (NNS rates))))))))))) (. .)) )
(TOP (S (NP (NN Rejection)) (VP (AUX has) (VP (AUX been) (NP (DT the) (JJ major) (NN obstacle)) (PP (IN in) (NP (NP (DT the) (QP (RB approximately) (CD 30,000)) (NN organ) (NNS transplants)) (VP (VBN performed) (ADVP (RB world-wide)) (NP (DT each) (NN year))))))) (. .)) )
(TOP (S (NP (NNS Researchers)) (VP (VBD began) (S (VP (VBG using) (NP (DT the) (NN drug)))) (PP (IN in) (NP (date (NNP February)))) (PP (IN on) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (AUX had) (VP (VBN received) (NP (NN kidney) (, ,) (NN liver) (, ,) (NN heart) (CC and) (NN pancreas) (NNS transplants))))))))) (. .)) )
(TOP (S (NP (QP (RB Only) (CD two) (IN of) (CD 111)) (NNS transplants)) (VP (AUX have) (VP (AUX been) (VP (VBN rejected)))) (. .)) )
(TOP (S (NP (NP (DT The) (NN drug)) (, ,) (VP (VBN discovered) (PP (IN in) (NP (date (CD 1984))))) (, ,)) (VP (AUX is) (VP (VBN metabolized) (PP (IN from) (NP (NP (NN soil) (NN fungus)) (VP (VBN found) (PP (IN in) (NP (location (NNP Japan))))))))) (. .)) )
(TOP (S (NP (DT The) (location (NNP Pittsburgh)) (NNS patients)) (VP (AUX are) (NP (NP (DT the) (JJ first) (NNS humans)) (SBAR (S (VP (TO to) (VP (AUX be) (VP (VBN given) (NP (NP (DT the) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (AUX is) (VP (VBN made) (PP (IN by) (NP (NNP Fujisawa) (NNP Pharmaceutical) (NNP Co))))))))))))))) (. .)) )
(TOP (SINV (`` `) (S (`` `) (NP (PRP We)) (VP (AUX 're) (VP (VBN shocked) (PP (IN by) (NP (PRP it))) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (AUX 's) (VP (VBN worked) (ADVP (RB so) (RB fast))))))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (person (NNP Dr.) (NNP Thomas) (NNP E.) (NNP Starzl))) (, ,) (NP (NP (NN director)) (PP (IN of) (NP (DT the) (organization (NAC (NNP University) (PP (IN of) (NP (NNP Pittsburgh)))) (NNP Transplantation) (NNP Program))))) (, ,)) (PP (IN at) (NP (DT a) (NN news) (NN conference))) (ADVP (RB here)) (NP (date (NN yesterday))) (. .)) )
(TOP (SINV (`` `) (S (`` `) (NP (PRP We)) (VP (VBP consider) (S (NP (PRP it)) (NP (DT a) (JJ life-saving) (NN drug)))) (, ,) (PP (IN like) (NP (NP (CD one)) (PP (IN for) (NP (NNP AIDS)))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (person (NNP Dr.) (NNP John) (NNP Fung))) (, ,) (NP (NP (DT an) (NN immunologist)) (PP (IN at) (NP (organization (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh)))))))) (. .)) )
(TOP (S (NP (NNS Researchers)) (VP (VBP say) (SBAR (S (NP (PRP they)) (VP (VBP believe) (SBAR (S (NP (NNP FK-506)) (VP (AUX is) (ADJP (ADJP (QP (CD 100) (NNS times)) (RBR more) (JJ effective)) (PP (IN than) (NP (NP (DT the) (JJ traditional) (JJ anti-rejection) (NN drug)) (, ,) (NP (NN cyclosporine)) (, ,) (VP (VBN made) (PP (IN by) (NP (JJ Swiss) (JJ pharmaceutical) (NN giant) (NNP Sandoz) (NNP Ltd)))))))))))))) (. .)) )
(TOP (S (NP (PRP They)) (VP (AUX are) (ADVP (RB also)) (VP (VBN encouraged) (PP (IN by) (NP (NP (DT the) (ADJP (RB relatively) (JJ mild)) (JJ side) (NNS effects)) (PP (IN of) (NP (NNP FK-506))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NN cyclosporine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB cause) (NP (NP (JJ renal) (NN failure)) (, ,) (NP (NN morbidity)) (, ,) (NP (NN nausea)) (CC and) (NP (JJ other) (NNS problems)))))))))))) (. .)) )
(TOP (S (`` `) (S (`` `) (NP (NP (DT The) (JJ side) (NNS effects)) (-LRB- -LCB-) (PP (IN of) (NP (NN cyclosporine))) (-RRB- -RCB-)) (VP (AUX have) (VP (VBN made) (S (NP (NP (DT the) (NN penalty)) (PP (IN for) (NP (PRP$ its) (NN success)))) (ADJP (RB rather) (JJ high))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said)) (. .)) )
(TOP (S (NP (NNP Dr.) (NNP Fung)) (VP (VBD said) (SBAR (SBAR (IN that) (S (NP (NNP FK-506)) (VP (MD would) (RB not) (VP (AUX be) (ADJP (JJ available)) (PP (IN in) (NP (DT the) (NN market))) (PP (IN for) (NP (QP (IN at) (JJS least) (DT a)) (NN year))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT the) (organization (NNP FDA)) (NN approval) (NN process)) (ADVP (RB usually)) (VP (VBZ takes) (NP (NP (CD three) (NNS years)) (TO to) (NP (CD five) (NNS years)))))))) (. .)) )
(TOP (S (NP (EX There)) (VP (AUX are) (NP (DT no) (JJ firm) (NNS plans) (S (VP (TO to) (VP (VB expand) (NP (DT the) (JJ experimental) (NN program)) (PP (IN beyond) (NP (NP (organization (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh))))) (, ,) (SBAR (WHNP (WP$ whose) (NN hospital)) (S (VP (VBZ performs) (NP (NP (DT the) (JJS most) (NNS transplants)) (PP (IN in) (NP (DT the) (NN world)))))))))))))) (. .)) )
(TOP (S (S (NP (NNS Researchers)) (VP (MD could) (RB n't) (VP (VB estimate) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (DT the) (NN drug)))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ reaches) (NP (DT the) (NN market)))))))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBD said) (SBAR (S (NP (NNP FK-506)) (VP (MD will) (VP (VB enable) (S (NP (NNS patients)) (VP (TO to) (VP (VP (VB cut) (NP (NN hospital) (NNS stays)) (PP (IN by) (NP (percentage (CD 50) (NN %))))) (CC and) (VP (VB reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN blood) (NNS tests)) (VP (VBN used) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NP (JJ cyclosporine)) (CC and) (NP (JJ other) (NNS drugs)))))))) (PP (IN among) (NP (NN transplant) (NNS recipients))))))))))))))))) (. .)) )
(TOP (S (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said) (SBAR (SBAR (S (NP (DT the) (NN research)) (VP (AUX has) (VP (AUX been) (ADVP (RB largely)) (VP (VBN financed) (PP (PP (IN by) (NP (organization (NP (DT the) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health)))))) (CC and) (PP (IN by) (NP (NN university) (NNS funds))) (, ,))))))) (CC and) (SBAR (IN that) (S (NP (NNP Fujisawa)) (VP (AUX did) (RB n't) (VP (VB give) (NP (DT the) (NN hospital)) (NP (DT any) (NNS grants)))))))) (. .)) )
(TOP (S (NP (PRP He)) (VP (VBD said) (SBAR (IN that) (S (NP (DT the) (NN research) (NN team)) (VP (AUX had) (NP (NP (DT no) (JJ financial) (NN stake)) (PP (IN in) (NP (DT the) (NN drug)))))))) (. .)) )
(TOP (S (`` `) (S (`` `) (S (NP (PRP We)) (VP (AUX 've) (VP (VBN known) (PP (IN for) (NP (CD six) (NNS months))) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT this) (NN drug))))))) (, ,) (CC and) (S (NP (NP (PRP$ our) (NN advice)) (PP (TO to) (NP (PRP$ our) (NNS people)))) (VP (AUX has) (VP (AUX been) (RB not) (VP (TO to) (VP (VB buy) (NP (NP (DT the) (NN company) (POS 's)) (NN stock))))))) (, ,) ('' ')) ('' ') (NP (NNP Dr.) (NNP Starzl)) (VP (VBD said) (, ,) (S (VP (VBG adding) (SBAR (IN that) (S (S (VP (VBG profiting) (PP (IN from) (NP (NNP FK-506))))) (VP (MD would) (RB n't) (VP (AUX be) (ADJP (JJ ethical))))))))) (. .)) )
